rozanolixizumab   Click here for help

GtoPdb Ligand ID: 9801

Synonyms: CA170_01519.g57 IgG4P | rozanolixizumab-noli | Rystiggo® | UCB-7665 | UCB7665
Approved drug Immunopharmacology Ligand
rozanolixizumab is an approved drug (FDA (2023))
Compound class: Antibody
Comment: Rozanolixizumab is an anti-human FcRn monoclonal antibody that is being developed for potential use in the treatment of IgG-driven autoimmune diseases [1,3-4].
Click here for help
Classification Click here for help
Compound class Antibody
Approved drug? Yes (FDA (2023))
International Nonproprietary Names Click here for help
INN number INN
10213 rozanolixizumab
Synonyms Click here for help
CA170_01519.g57 IgG4P | rozanolixizumab-noli | Rystiggo® | UCB-7665 | UCB7665
Database Links Click here for help
GtoPdb PubChem SID 354702273
Search PubMed clinical trials rozanolixizumab
Search PubMed titles rozanolixizumab
Search PubMed titles/abstracts rozanolixizumab